Clinical Trial Update: Efficacy and Safety of Astragalus for Non-motor Symptoms of α-Synucleinopathy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing efficacy and safety of Astragalus for non-motor symptoms in α-synucleinopathy (Parkinsonism).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease
• Parkinsonism

Drugs mentioned

• Astragalus (Astragalus membranaceus)

Snippet

Sponsor: Fujian Medical University Union Hospital | Conditions: Parkinsonism | Phase 2 | Status: UNKNOWN